OJOph  Vol.3 No.4 , November 2013
Cryotherapy in Ophthalmology
ABSTRACT

Cryogens have been used to freeze living tissue for the purpose of treating benign and malignant lesions. Within the last century, ophthalmologists have found cryotherapy to be useful in treating a variety of ocular pathologies. Here, we review the history of cryotherapy, its introduction to the field of ophthalmology, its proposed mechanism of action, and its current applications in treating surface and intraocular eye disease.


Cite this paper
S. Tehrani and F. Fraunfelder, "Cryotherapy in Ophthalmology," Open Journal of Ophthalmology, Vol. 3 No. 4, 2013, pp. 103-117. doi: 10.4236/ojoph.2013.34024.
References
[1]   R. R. Lubritz, “Cryosurgery,” Clinics in Dermatology, Vol. 5, No. 4, 1987, pp. 120-127.
http://dx.doi.org/10.1016/0738-081X(87)90033-2

[2]   S. M. Cooper and R. P. Dawber, “The History of Cryosurgery,” Journal of the Royal Society of Medicine, Vol. 94, No. 4, 2001, pp. 196-201.

[3]   A. Freiman and N. Bouganim, “History of Cryotherapy,” Dermatology Online Journal, Vol. 11, No. 2, 2005, p. 9.

[4]   A. Squazzi and D. Bracco, “A Historical Account of the Technical Means Used in Cryotherapy,” Minerva Medica, Vol. 65, No. 70, 1974, pp. 3718-3722.

[5]   A. Brock, “Greek Medicine, Being Extracts Illustrative of Medical Writers from Hippocrates to Galen,” 2nd Edition, Dutton, New York, 1972.

[6]   J. Arnott, “On the Treatment of Cancer by the Regulated Application of an Anaesthetic Temperature,” Churchill, London, 1851.

[7]   A. White, “Liquid Air: Its Application in Medicine and Surgery,” Medication Reconciliation, Vol. 56, 1899, pp. 109-112.

[8]   A. White, “Possibilities of Liquid Air to the Physcian,” JAMA, Vol. 36, No. 7, 1901, pp. 426-429.
http://dx.doi.org/10.1001/jama.1901.52470070012001d

[9]   H. G. Irvine and D. D. Turnacliff, “Liquid Oxygen in Dermatology,” Arch Dermatol Syphilol, Vol. 19, No. 2, 1929, pp. 270-280.
http://dx.doi.org/10.1001/archderm.1929.02380200098007

[10]   H. Allington, “Liquid Nitrogen in the Treatment of Skin Disease,” California Medicine, Vol. 72, No. 3, 1950, p. 153.

[11]   I. S. Cooper and T. Hirose, “Application of Cryogenic Surgery to Resection of Parenchymal Organs,” The New England Journal of Medicine, Vol. 274, No. 1, 1966, pp. 15-18. http://dx.doi.org/10.1056/NEJM196601062740103

[12]   S. Zacarian, “Cryogenics: The Cryolesion and the Pathogenesis of Cryonecrosis, in Cryosurgery for Skin Cancer and Cutaneous Disorders,” St. Louis, Mosby, 1985, pp. 1-30.

[13]   P. Lepivert, “Predictability of Cryonecrosis by Tissue Impedancemetry,” Low Temperature Medicine, Vol. 4, 1977, p. 129.

[14]   S. A. Zacarian, “Cryosurgery of Cutaneous Carcinomas. An 18-Year Study of 3,022 Patients with 4,228 Carcinomas,” Journal of the American Academy of Dermatology, Vol. 9, No. 6, 1983, pp. 947-956.
http://dx.doi.org/10.1016/S0190-9622(83)70213-6

[15]   D. Bracco, “The Historic Development of Cryosurgery,” Clinics in Dermatology, Vol. 8, No. 1, 1990, pp. 1-4.
http://dx.doi.org/10.1016/0738-081X(90)90061-5

[16]   G. F. Graham, “Cryosurgery,” Clinics in Plastic Surgery, Vol. 20, No. 1, 1993, pp. 131-147.

[17]   G. Bietti, “Ricerche Sulle Variazione di Temperature di Alcune Zone del Bulbo Oculaire per Diatermocoagulaxioni Episclerali, Termocauterizazioni e Criocausticazioni,” Bollettino d’Oculistica, Vol. 12, 1933, pp. 1427-1457.

[18]   R. Deutschmann, “Die Behandlung der Netzhautablosung mit Jodtinkur und Kohlensaureschnee,” Klin Montasbl Augenh, Vol. 94, 1935, p. 349.

[19]   T. Krwawicz, “Intracapsular Extraction of Intumescent Cataract by Application of Low Temperature,” The British Journal of Ophthalmology, Vol. 45, No. 4, 1961, pp. 279-283. http://dx.doi.org/10.1136/bjo.45.4.279

[20]   S. P. Amoils, “The Joule Thomson Cryoprobe,” Archives of Ophthalmology, Vol. 78, No. 2, 1967, pp. 201-207.
http://dx.doi.org/10.1001/archopht.1967.00980030203014

[21]   J. G. Bellows, “Indications and Technique of Cryoextraction of Cataracts,” Archives of Ophthalmology, Vol. 73, No. 4, 1965, pp. 476-481.
http://dx.doi.org/10.1001/archopht.1965.00970030478006

[22]   J. G. Bellows, “The Application of Cryogenic Techniques in Ophthalmology,” American Journal of Ophthalmology, Vol. 57, 1964, pp. 29-33.

[23]   C. D. Kelman, “Cryosurgery for Cataract Extracction and the Treatment of Other Eye Diseases,” Highlights Ophthalmol, Vol. 7, 1964, pp. 181-209.

[24]   J. G. Bellows, “Cryotherapy of Ocular Disease,” J.B. Lippincott Co., Philadelphia, 1966.

[25]   H. A. Lincoff, J. M. McLean and H. Nano, “Cryosurgical Treatment of Retinal Detachment. Transactions,” American Academy of Ophthalmology and Otolaryngology, Vol. 68, 1964, pp. 412-432.

[26]   C. L. Schepens, I. D. Okamura and R. J. Brockhurst, “The Scleral Buckling Procedures. I. Surgical Techniques and Management,” Archives of Ophthalmology, Vol. 58, No. 6, 1957, pp. 797-811.
http://dx.doi.org/10.1001/archopht.1957.00940010819003

[27]   J. I. Barraquer, “Method for Cutting Lamellar Grafts in Frozen Cornea, New Orientation for Refractive Surgery,” Arch Soc Am Ophthal Optom, Vol. 1, 1958, pp. 271-286.

[28]   Herbert E. Kaufman, “Preserving Corneas by Freezing,” Archives of Ophthalmology, Vol. 73, No. 6, 1965, pp. 907-908.
http://dx.doi.org/10.1001/archopht.1965.00970030909029

[29]   S. A. Zacarian, “Cancer of the Eyelid—A Cryosurgical Approach,” Annals of Ophthalmology, Vol. 4, No. 6, 1972, pp. 473-480.

[30]   H. E. Farris and F. T. Fraunfelder, “Cryosurgical Treatment of Ocular Squamous Cell Carcinoma of Cattle,” Journal of the American Veterinary Medical Association, Vol. 168, No. 3, 1976, pp. 213-216.

[31]   H. E. Farris, F. T. Fraunfelder and C. H. Frith, “A Simple Cryosurgical Unit for Treatment of Animal Tumors,” Veterinary Medicine, Small Animal Clinician, Vol. 70, No. 3, 1975, pp. 299-302.

[32]   F. T. Fraunfelder, H. Howard and M. L. Ray, “New Therapy Method for Cancer Eye in Cattle,” Southern Beef Producer, Vol. 5, 1974.

[33]   F. T. Fraunfelder, et al., “The Role of Cryosurgery in External Ocular and Periocular Disease,” Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology, Vol. 83, No. 4, 1977, pp. 713-724.

[34]   F. T. Fraunfelder, H. E. Farris Jr. and T. R. Wallace, “Cryosurgery for Ocular and Periocular Lesions,” The Journal of Dermatologic Surgery and Oncology, Vol. 3, No. 4, 1977, pp. 422-427.

[35]   F. T. Fraunfelder, et al., “Results of Cryotherapy for Eyelid Malignancies,” American Journal of Ophthalmology, Vol. 97, No. 2, 1984, pp. 184-188.

[36]   E. G. Kuflik and A. A. Gage, “The Five-Year Cure Rate Achieved by Cryosurgery for Skin Cancer,” Journal of the American Academy of Dermatology, Vol. 24, No. 6, 1991, pp. 1002-1004.
http://dx.doi.org/10.1016/0190-9622(91)70160-4

[37]   P. J. Holt, “Cryotherapy for Skin Cancer: Results over a 5-Year Period Using Liquid Nitrogen Spray Cryosurgery,” The British Journal of Dermatology, Vol. 119, No. 2, 1988, pp. 231-240.
http://dx.doi.org/10.1111/j.1365-2133.1988.tb03205.x

[38]   E. G. Kuflik and A. A. Gage, “Recurrent Basal Cell Carcinoma Treated with Cryosurgery,” Journal of the American Academy of Dermatology, Vol. 37, No. 1, 1997, pp. 82-84. http://dx.doi.org/10.1016/S0190-9622(97)70215-9

[39]   F. Jaramillo-Ayerbe, “Cryosurgery in Difficult to Treat Basal Cell Carcinoma,” International Journal of Dermatology, Vol. 39, No. 3, 2000, pp. 223-229.
http://dx.doi.org/10.1046/j.1365-4362.2000.00952.x

[40]   F. T. Fraunfelder, et al., “Cryosurgery for Malignancies of the Eyelid,” Ophthalmology, Vol. 87, No. 6, 1980, pp. 461-465.

[41]   M. D. Eichler and F. T. Fraunfelder, “Cryotherapy for Conjunctival Lymphoid Tumors,” American Journal of Ophthalmology, Vol. 118, No. 4, 1994, pp. 463-467.

[42]   F. A. Jakobiec, et al., “Cryotherapy for Conjunctival Primary Acquired Melanosis and Malignant Melanoma. Experience with 62 Cases,” Ophthalmology, Vol. 95, No. 8, 1988, pp. 1058-1070.

[43]   F. T. Fraunfelder and D. Wingfield, “Management of Intraepithelial Conjunctival Tumors and Squamous Cell Carcinomas,” American Journal of Ophthalmology, Vol. 95, No. 3, 1983, pp. 359-363.

[44]   F. W. Fraunfelder and F. T. Fraunfelder, “Liquid Nitrogen Cryotherapy of a Conjunctival Vascular Tumor,” Cornea, Vol. 24, No. 1, 2005, pp. 116-117.
http://dx.doi.org/10.1097/01.ico.0000134185.55310.1d

[45]   C. D. Kelman and I. S. Cooper, “Cryogenic Ophthalmic Surgery,” American Journal of Ophthalmology, Vol. 56, 1963, pp. 731-739.

[46]   T. D. Wilkes and F. T. Fraunfelder, “Principles of Cryosurgery,” Ophthalmic Surgery, Vol. 10, No. 8, 1979, pp. 21-30.

[47]   D. L. Wingfield and F. T. Fraunfelder, “Possible Complications Secondary to Cryotherapy,” Ophthalmic Surgery, Vol. 10, No. 8, 1979, pp. 47-55.

[48]   S. M. Tucker, et al., “Scleral Melt after Cryotherapy for Conjunctival Melanoma,” Ophthalmology, Vol. 100, No. 4, 1993, pp. 574-577.

[49]   J. H. Sullivan, “Cryosurgery in Ophthalmic Practice,” Ophthalmic Surgery, Vol. 10, No. 8, 1979, pp. 37-41.

[50]   W.-L. Yang, T. Addona, D. G. Nair, L. X. Qi and T. S. Ravikumar, “Apoptosis Induced by Cryoinjury in Human Colorectal Cancer Cells Is Associated with Mitochondrial Dysfunction,” International Journal of Cancer, Vol. 103, No. 3, 2003, pp. 360-369.
http://dx.doi.org/10.1002/ijc.10822

[51]   H. T. Mergman, “Mechanics of Freezing in Living Cells and Tissues,” Science, Vol. 124, 1956, pp. 15-30.

[52]   D. Torre, “Cryosurgical Instrumentation and Depth Dose Monitoring,” In: E. D.-S. Breitbart, Ed., Clinics in Dermatology: Advances in Cryosurgery, Elsevier, New York, 1990, p. 48.

[53]   G. D’Aversa, et al., “Advancing Wave-Like Epitheliopathy. Clinical Features and Treatment,” Ophthalmology, Vol. 104, No. 6, 1997, pp. 962-969.
http://dx.doi.org/10.1016/S0161-6420(97)30199-7

[54]   F. W. Fraunfelder, “Liquid Nitrogen Cryotherapy of Advancing Wavelike Epitheliopathy,” Cornea, Vol. 25, No. 2, 2006, pp. 196-198.
http://dx.doi.org/10.1097/01.ico.0000170691.67584.ec

[55]   I. Leibovitch, et al., “Periocular and Orbital Amyloidosis: Clinical Characteristics, Management, and Outcome,” Ophthalmology, Vol. 113, No. 9, 2006, pp. 1657-1664.
http://dx.doi.org/10.1016/j.ophtha.2006.03.052

[56]   H. Demirci, et al., “Conjunctival Amyloidosis: Report of Six Cases and Review of the Literature,” Survey of Ophthalmology, Vol. 51, No. 4, 2006, pp. 419-433.
http://dx.doi.org/10.1016/j.survophthal.2006.04.007

[57]   M. B. Pepys, “Amyloidosis,” Annual Review of Medicine, Vol. 57, 2006, pp. 223-241.
http://dx.doi.org/10.1146/annurev.med.57.121304.131243

[58]   F. W. Fraunfelder, “Liquid Nitrogen Cryotherapy for Surface Eye Disease (an AOS Thesis),” Transactions of the American Ophthalmological Society, Vol. 106, 2008, pp. 301-324.

[59]   F. W. Fraunfelder, “Liquid Nitrogen Cryotherapy for Conjunctival Amyloidosis,” Archives of Ophthalmology, Vol. 127, No. 5, 2009, pp. 645-648.
http://dx.doi.org/10.1001/archophthalmol.2008.535

[60]   H. D. Perry and A. J. Cossari, “Chronic Lymphangiectasis in Turner’s Syndrome,” The British Journal of Ophthalmology, Vol. 70, No. 5, 1986, pp. 396-399.
http://dx.doi.org/10.1136/bjo.70.5.396

[61]   L. M. Jampol and K. C. Nagpal, “Hemorrhagic Lymphangiectasia of the Conjunctiva,” American Journal of Ophthalmology, Vol. 85, 1978, pp. 419-420.

[62]   I. A. Wasfy, “Lymphangiectasia Haemorrhagica Conjunctivae: Report of Three Cases with a Note on Successful Treatment with Cryosurgery in One Case,” Bulletin of the Ophthalmological Society of Egypt, Vol. 68, 1975, pp. 37-44.

[63]   F. W. Fraunfelder, “Liquid Nitrogen Cryotherapy of Conjunctival Lymphangiectasia: A Case Series,” Archives of Ophthalmology, Vol. 127, No. 12, 2009, pp. 1686-1687.
http://dx.doi.org/10.1001/archophthalmol.2009.306

[64]   A. Rothova, “Ocular Involvement in Sarcoidosis,” The British Journal of Ophthalmology, Vol. 84, No. 1, 2000, pp. 110-116. http://dx.doi.org/10.1136/bjo.84.1.110

[65]   J. Y. Oh and W. R. Wee, “Cyclosporine for Conjunctival Sarcoidosis,” Ophthalmology, Vol. 115, No. 1, 2008, p. 222. http://dx.doi.org/10.1016/j.ophtha.2007.08.024

[66]   F. W. Fraunfelder and D. S. Dhoot, “Successful Treatment of Conjunctival Sarcoidosis with Local Cryotherapy,” Ophthalmic Surgery, Lasers & Imaging: The Official Journal of the International Society for Imaging in the Eye, 2010, pp. 1-4.

[67]   I. J. Wang, et al., “Mechanism of Abnormal Elastin Gene Expression in the Pinguecular Part of Pterygia,” The American Journal of Pathology, Vol. 157, No. 4, 2000, pp. 1269-1276.
http://dx.doi.org/10.1016/S0002-9440(10)64642-1

[68]   M. T. Coroneo, N. Di Girolamo and D. Wakefield, “The Pathogenesis of Pterygia,” Current Opinion in Ophthalmology, Vol. 10, No. 4, 1999, pp. 282-288.
http://dx.doi.org/10.1097/00055735-199908000-00011

[69]   T. M. Nolan, et al., “The Role of Ultraviolet Irradiation and Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Pathogenesis of Pterygium,” The American Journal of Pathology, Vol. 162, No. 2, 2003, pp. 567-574.
http://dx.doi.org/10.1016/S0002-9440(10)63850-3

[70]   M. Gebhardt, et al., “Differential Expression of Vascular Endothelial Growth Factor Implies the Limbal Origin of Pterygia,” Ophthalmology, Vol. 112, No. 6, 2005, pp. 1023-1030.
http://dx.doi.org/10.1016/j.ophtha.2005.01.023

[71]   P. Sakoonwatanyoo, D. T. Tan and D. R. Smith, “Expression of p63 in Pterygium and Normal Conjunctiva,” Cornea, Vol. 23, No. 1, 2004, pp. 67-70.
http://dx.doi.org/10.1097/00003226-200401000-00011

[72]   Donaldson, K.E.A., E.C., “Recent Advances in Pterygium Excision,” Cont Ophthalmol, Vol. 2, 2003, pp. 1-7.

[73]   F. W. Fraunfelder, “Cryotherapy for Pterygia,” Ophthalmology, Vol. 115, No. 12, 2008, pp. 2314-2314.

[74]   I. Cher, “Superior Limbic Keratoconjunctivitis: Multifactorial Mechanical Pathogenesis,” Clinical & Experimental Ophthalmology, Vol. 28, No. 3, 2000, pp. 181-184.
http://dx.doi.org/10.1046/j.1442-9071.2000.00284.x

[75]   N. Yokoi, et al., “New Surgical Treatment for Superior Limbic Keratoconjunctivitis and Its Association with Conjunctivochalasis,” American Journal of Ophthalmology, Vol. 135, No. 3, 2003, pp. 303-308.
http://dx.doi.org/10.1016/S0002-9394(02)01975-X

[76]   J. D. Nelson, “Superior Limbic Keratoconjunctivitis (SLK),” Eye, Vol. 3, Pt. 2, 1989, pp. 180-189.
http://dx.doi.org/10.1038/eye.1989.26

[77]   H. Y. Yang, et al., “Lacrimal Punctal Occlusion for the Treatment of Superior Limbic Keratoconjunctivitis,” American Journal of Ophthalmology, Vol. 124, No. 1, 1997, pp. 80-87.

[78]   E. Goto, et al., “Treatment of Superior Limbic Keratoconjunctivitis by Application of Autologous Serum,” Cornea, Vol. 20, No. 8, 2001, pp. 807-810.
http://dx.doi.org/10.1097/00003226-200111000-00006

[79]   H. D. Perry, et al., “Topical Cyclosporine A 0.5% as a Possible New Treatment for Superior Limbic Keratoconjunctivitis,” Ophthalmology, Vol. 110, No. 8, 2003, pp. 1578-1581.
http://dx.doi.org/10.1016/S0161-6420(03)00538-4

[80]   I. J. Udell, A. C. Guidera and J. Madani-Becker, “Ketotifen Fumarate Treatment of Superior Limbic Keratoconjunctivitis,” Cornea, Vol. 21, No. 8, 2002, pp. 778-780.
http://dx.doi.org/10.1097/00003226-200211000-00009

[81]   S. Watson, A. B. Tullo and F. Carley, “Treatment of Superior Limbic Keratoconjunctivitis with a Unilateral Bandage Contact Lens,” The British Journal of Ophthalmology, Vol. 86, No. 4, 2002, pp. 485-486.
http://dx.doi.org/10.1136/bjo.86.4.485

[82]   R. D. Grutzmacher, R. S. Foster and L. S. Feiler, “Lodoxamide Tromethamine Treatment for Superior Limbic Keratoconjunctivitis,” American Journal of Ophthalmology, Vol. 120, No. 3, 1995, pp. 400-402.

[83]   I. A. Mackie, “Management of Superior Limbic Keratoconjunctivitis with Botulinum Toxin,” Eye, Vol. 9, Pt. 1, 1995, pp. 143-144. http://dx.doi.org/10.1038/eye.1995.25

[84]   Y. Ohashi, et al., “Vitamin A Eyedrops for Superior Limbic Keratoconjunctivitis,” American Journal of Ophthalmology, Vol. 105, No. 5, 1988, pp. 523-527.

[85]   E. F. Kadrmas and G. B. Bartley, “Superior Limbic Keratoconjunctivitis. A Prognostic Sign for Severe Graves Ophthalmopathy,” Ophthalmology, Vol. 102, No. 10, 1995, pp. 1472-1475.

[86]   F. W. Fraunfelder, “Liquid Nitrogen Cryotherapy of Superior Limbic Keratoconjunctivitis,” American Journal of Ophthalmology, Vol. 147, No. 2, 2009, pp. 234-238.

[87]   J. H. Sullivan, “The Use of Cryotherapy for Trichiasis. Transactions. Section on Ophthalmology,” American Academy of Ophthalmology and Otolaryngology, Vol. 83, No. 4, Pt. 1, 1977, pp. 708-712.

[88]   F. T. Fraunfelder and G. J. Petursson, “The Use of Liquid Nitrogen Cryospray for Treatment of Trichiasis,” Ophthalmic Surgery, Vol. 10, No. 8, 1979, pp. 42-46.

[89]   C. D. Rice, R. C. Kersten and S. Al-Hazzaa, “Cryotherapy for Trichiasis in Trachoma,” Archives of Ophthalmology, Vol. 107, No. 8, 1989, pp. 1180-1182.
http://dx.doi.org/10.1001/archopht.1989.01070020246033

[90]   M. J. Elder and W. Bernauer, “Cryotherapy for Trichiasis in Ocular Cicatricial Pemphigoid,” The British Journal of Ophthalmology, Vol. 78, No. 10, 1994, pp. 769-771.
http://dx.doi.org/10.1136/bjo.78.10.769

[91]   N. Kumagai, et al., “Role of Structural Cells of the Cornea and Conjunctiva in the Pathogenesis of Vernal Keratoconjunctivitis,” Progress in Retinal and Eye Research, Vol. 25, No. 2, 2006, pp. 165-187.
http://dx.doi.org/10.1016/j.preteyeres.2005.09.002

[92]   G. Singh, “Cryosurgery in Palpebral Vernal Catarrh,” Annals of Ophthalmology, Vol. 14, No. 3, 1982, pp. 252-254.

[93]   A. Abiose and M. Merz, “Cryosurgery in the Management of Vernal Keratoconjunctivitis,” Annals of Ophthalmology, Vol. 15, No. 8, 1983, pp. 744-747.

[94]   A. T. Mtanda and J. L. Sangawe, “Cryosurgery in Vernal Catarrh,” Tropical and Geographical Medicine, Vol. 35, No. 4, 1983, pp. 381-383.

[95]   T. Sankarkumar, A. Panda and S. K. Angra, “Efficacy of Cryotherapy in Vernal Catarrh,” Annals of Ophthalmology, Vol. 24, No. 7, 1992, pp. 253-256.

[96]   D. Jiang, M. Zhang and Y. Hu, “Resection and Cryotherapy Combined with Amniotic Membrane Transplantation for the Treatment of Vernal Keratoconjunctivitis with Giant Papillae,” Journal of Huazhong University of Science and Technology. Medical Sciences, Vol. 26, No. 5, 2006, pp. 618-620.

[97]   P. Gloor and G. Alexandrakis, “Clinical Characterization of Primary Acquired Melanosis,” Investigative Ophthalmology & Visual Science, Vol. 36, No. 8, 1995, pp. 1721-1729.

[98]   J. A. Shields, et al., “Primary Acquired Melanosis of the Conjunctiva: Experience with 311 Eyes,” Transactions of the American Ophthalmological Society, Vol. 105, 2007, pp. 61-71, Discussion 71-72.

[99]   S. Brownstein, et al., “Cryotherapy for Precancerous Melanosis (Atypical Melanocytic Hyperplasia) of the Conjunctiva,” Archives of Ophthalmology, Vol. 99, No. 7, 1981, pp. 1224-1231.
http://dx.doi.org/10.1001/archopht.1981.03930020098009

[100]   J. A. Shields, C. L. Shields and P. De Potter, “Surgical Management of Conjunctival Tumors. The 1994 Lynn B. McMahan Lecture,” Archives of Ophthalmology, Vol. 115, No. 6, 1997, pp. 808-815.
http://dx.doi.org/10.1001/archopht.1997.01100150810025

[101]   R. Folberg, I. W. McLean and L. E. Zimmerman, “Conjunctival Melanosis and Melanoma,” Ophthalmology, Vol. 91, No. 6, 1984, pp. 673-678.

[102]   A. S. Grove Jr., “Melanomas of the Conjunctiva,” International Ophthalmology Clinics, Vol. 20, No. 2, 1980, pp. 161-175.

[103]   F. A. Jakobiec, et al., “Combined Surgery and Cryotherapy for Diffuse Malignant Melanoma of the Conjunctiva,” Archives of Ophthalmology, Vol. 98, No. 8, 1980, pp. 1390-1396.
http://dx.doi.org/10.1001/archopht.1980.01020040242005

[104]   J. M. McDonnell, A. J. Mayr and W. J. Martin, “DNA of Human Papillomavirus Type 16 in Dysplastic and Malignant Lesions of the Conjunctiva and Cornea,” The New England Journal of Medicine, Vol. 320, No. 22, 1989, pp. 1442-1446. http://dx.doi.org/10.1056/NEJM198906013202202

[105]   G. Peksayar, M. K. Soyturk and M. Demiryont, “Long-Term Results of Cryotherapy on Malignant Epithelial Tumors of the Conjunctiva,” American Journal of Ophthalmology, Vol. 107, No. 4, 1989, pp. 337-340.

[106]   M. Tunc, et al., “Intraepithelial and Invasive Squamous Cell Carcinoma of the Conjunctiva: Analysis of 60 Cases,” The British Journal of Ophthalmology, Vol. 83, No. 1, 1999, pp. 98-103.
http://dx.doi.org/10.1136/bjo.83.1.98

[107]   A. Al-Muammar, W. G. Hodge and J. Farmer, “Conjunctival T-Cell Lymphoma: A Clinicopathologic Case Report,” Ophthalmology, Vol. 113, No. 3, 2006, pp. 459-461. http://dx.doi.org/10.1016/j.ophtha.2005.10.042

[108]   P. S. Tsai and K. A. Colby, “Treatment of Conjunctival Lymphomas,” Seminars in Ophthalmology, Vol. 20, No. 4, 2005, pp. 239-246.
http://dx.doi.org/10.1080/08820530500350845

[109]   C. D. Kelman, “Cryosurgery for Cataract Extraction and the Treatment of Other Eye Diseases,” Highlights of Ophthalmology, Vol. 7, 1964, pp. 181-209.

[110]   M. Yanoff, “Prophylactic Cryotherapy of Retinal Breaks,” Annals of Ophthalmology, Vol. 9, No. 3, 1977, pp. 283-286.

[111]   T. J. Wolfensberger, G. W. Aylward and P. K. Leaver, “Prophylactic 360 Degrees Cryotherapy in Fellow Eyes of Patients with Spontaneous Giant Retinal Tears,” Ophthalmology, Vol. 110, No. 6, 2003, pp. 1175-1177.
http://dx.doi.org/10.1016/S0161-6420(03)00256-2

[112]   R. W. Kimball, P. H. Morse and W. E. Benson, “Cystoid Macular Edema after Cryotherapy,” American Journal of Ophthalmology, Vol. 86, No. 4, 1978, pp. 572-573.

[113]   E. H. Jaccoma, B. P. Conway and P. A. Campochiaro, “Cryotherapy Causes Extensive Breakdown of the Blood-Retinal Barrier. A Comparison with Argon Laser Photo-coagulation,” Archives of Ophthalmology, Vol. 103, No. 11, 1985, pp. 1728-1730.
http://dx.doi.org/10.1001/archopht.1985.01050110124039

[114]   R. J. Bowman, et al., “Retinal Necrosis as a Complication of Cryotherapy,” Eye, Vol. 8, Pt. 5, 1994, pp. 600-601.
http://dx.doi.org/10.1038/eye.1994.146

[115]   R. P. Lira, et al., “Cryotherapy vs Laser Photocoagulation in Scleral Buckle Surgery: A Randomized Clinical Trial,” Archives of Ophthalmology, Vol. 128, No. 12, 2010, pp. 1519-1522.
http://dx.doi.org/10.1001/archophthalmol.2010.271

[116]   N. W. Hindle and J. Leyton, “Prevention of Cicatricial Retrolental Fibroplasia by Cryotherapy,” Canadian Journal of Ophthalmology, Vol. 3, No. 4, 1978, pp. 277-282.

[117]   Cryotherapy for Retinopathy of Prematurity Cooperative Group, “Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Preliminary Results,” Archives of Ophthalmology, Vol. 106, No. 4, 1988, pp. 471-479.
http://dx.doi.org/10.1001/archopht.1988.01060130517027

[118]   Cryotherapy for Retinopathy of Prematurity Cooperative Group, “The Natural Ocular Outcome of Premature Birth and Retinopathy. Status at 1 Year,” Archives of Ophthalmology, Vol. 112, No. 7, 1994, pp. 903-912.
http://dx.doi.org/10.1001/archopht.1994.01090190051021

[119]   Cryotherapy for Retinopathy of Prematurity Cooperative Group, “Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Snellen Visual Acuity and Structural Outcome at 5 1/2 Years after Randomization,” Archives of Ophthalmology, Vol. 114, No. 4, 1996, pp. 417-424.
http://dx.doi.org/10.1001/archopht.1996.01100130413008

[120]   Cryotherapy for Retinopathy of Prematurity Cooperative Group, “Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Ophthalmological Outcomes at 10 Years,” Archives of Ophthalmology, Vol. 119, No. 8, 2001, pp. 1110-1118.
http://dx.doi.org/10.1001/archopht.119.8.1110

[121]   H. A. Mintz-Hittner, K. A. Kennedy and A. Z. Chuang, “Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity,” The New England Journal of Medicine, Vol. 364, No. 7, 2011, pp. 603-615.
http://dx.doi.org/10.1056/NEJMoa1007374

[122]   R. R. Lonser, et al., “Von Hippel-Lindau Disease,” Lancet, Vol. 361, No. 9374, 2003, pp. 2059-2067.
http://dx.doi.org/10.1016/S0140-6736(03)13643-4

[123]   A. D. Singh, et al., “Retinal Capillary Hemangioma: A Comparison of Sporadic Cases and Cases Associated with von Hippel-Lindau Disease,” Ophthalmology, Vol. 108, No. 10, 2001, pp. 1907-1911.
http://dx.doi.org/10.1016/S0161-6420(01)00758-8

[124]   E. Y. Chew, “Ocular Manifestations of von Hippel-Lindau Disease: Clinical and Genetic Investigations,” Transactions of the American Ophthalmological Society, Vol. 103, 2005, pp. 495-511.

[125]   A. D. Singh, et al., “Treatment of Retinal Capillary Hemangioma,” Ophthalmology, Vol. 109, No. 10, 2002, pp. 1799-1806.
http://dx.doi.org/10.1016/S0161-6420(02)01177-6

 
 
Top